Zymeworks has entered an exclusive global license and collaboration agreement with Roche to develop and commercialize ZW209, a trispecific T cell engager targeting DLL3 for cancer treatment. Zymeworks will receive $55 million upfront and $40 million upon starting Phase 1b trials, plus up to $718 million in milestone payments and royalties on sales. Roche will fund the Phase 1a trial and handle global development and commercialization. This partnership leverages Zymeworks' antibody technology and Roche's global capabilities to advance ZW209, currently in early clinical trials for lung and neuroendocrine cancers.
Zymeworks' licensing deal with Roche for ZW209 provides context for the health sector's market activity on Pluang. As of Oct 23, 2026 15:31 WIB, out of 150 priced health-sector US stocks, 49 rose and 90 fell. Notable movers include IBRX at USD 8.19 with a -1.44% change, CYTK at USD 63.21 with a +1.41% change, and INO at USD 0.85 with a +1.38% change and a typical hold time of 43 days.
Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
